companydata.dkcompanydata.dk

KEMIFARMA Consulting ApS: Financial statements 2024

CVR: 34709955

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -96,547 and a net result of DKK -378,700 compared with DKK 662,880 the year before. Equity in the 2024 report amounted to DKK 3,122,637. The solvency ratio was 99.3%. The company had 1 employee in the financial year.

Gross Profit
DKK -96,547
Profit/Loss
DKK -378,700
Equity
DKK 3,122,637
Total Assets
DKK 3,145,120
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--97K-379K3.1M1
2023-1.4M663K3.8M1
2022-1.1M189K3.3M1
2021--122K410K3.1M-
2020--15K392K2.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

KEMIFARMA Consulting ApS: The 2023 annual report is outJun 4, 2024

KEMIFARMA Consulting ApS has published its annual report for 2023. Gross profit came to DKK 1,388,626, and the net result was DKK 662,880.

About KEMIFARMA Consulting ApS

KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.

Source: annual report 2025, Danish Business Authority